stockrowAbbott Laboratories
ABT Healthcare Medical Devices
Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- −43.6%
- Free cash flow
- +28.9%
- Total debt
- +142.7%
Quarter to September 2026, against a year earlier
Follow ABT
Alert me
Abbott Laboratories (ABT) Revenue growth
Abbott Laboratories's revenue growth over the twelve months to 30 September 2026 was 10.0%, up 4.3 percentage points from fiscal 2025 (5.67%). Over the past ten years it has ranged from −8.12% (fiscal 2023) to 31.4% (fiscal 2017); the current reading is higher than 64% of that period. That is in line with the Medical Devices industry median of 10.4% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 5.67% | 1.08 |
| FY2024 | 4.59% | 12.71 |
| FY2023 | −8.12% | (9.46) |
| FY2022 | 1.34% | (23.13) |
| FY2021 | 24.5% | 15.99 |
| FY2020 | 8.48% | 4.14 |
| FY2019 | 4.34% | (7.30) |
| FY2018 | 11.6% | (19.71) |
| FY2017 | 31.4% | 29.15 |
| FY2016 | 2.20% | 1.42 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 14.5% | 1.44 |
| Jun 2026 | 13.0% | 5.24 |
| Mar 2026 | 7.78% | 3.36 |
| Dec 2025 | 4.42% | (2.48) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| EW Edwards Lifesciences Corporation compare | 13.4% |
| DXCM DexCom, Inc. compare | 13.0% |
| ABT Abbott Laboratories | 10.0% |
| MDT Medtronic PLC compare | 9.77% |
| BSX Boston Scientific Corporation compare | 8.87% |
| STE STERIS plc compare | 8.12% |
| PHG Koninklijke Philips N.V. compare | 7.98% |
| SYK Stryker Corporation compare | 7.87% |
| GEHC GE HealthCare Technologies Inc. compare | 6.87% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ABT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement